Unique ID issued by UMIN | UMIN000013060 |
---|---|
Receipt number | R000015165 |
Scientific Title | The efficacy of the eradication of Helicobacter pylori for quality of life -Multicenter clinical study- |
Date of disclosure of the study information | 2014/02/03 |
Last modified on | 2016/03/20 10:24:52 |
The efficacy of the eradication of Helicobacter pylori for quality of life
-Multicenter clinical study-
Kagoshima pylori study
The efficacy of the eradication of Helicobacter pylori for quality of life
-Multicenter clinical study-
Kagoshima pylori study
Japan |
Helicobacter infection without other orgnic disease
Gastroenterology | Adult |
Others
NO
Since H. pylori infection as well as the digestive tract associated with blood disorders, allergic diseases etc. have been reported, the possibility that inhibit QOL potentially some influence on various fields. Upper abdominal symptoms caused by H. pylori infection if the cause of QOL inhibition, improvement of QOL by eradication can be expected of course. However, there are few reports that whether H. pylori eradication improved QOL of patients without upper abdominal symptoms. By performing the eradication of the patients with or without upper abdominal symptoms, we will be able to build a new evidence of H. pylori eradication.
Efficacy
Evaluation of quality of life before and after Helicbacter pylori eradication
1.Effect of full dose of administration of proton pump inhibitor for upper abdominal symptoms in before and after eradication of Helicobacter pylori.
2.Evaluation of the successful rate of eradication of Helicobacter pylori by preceding PPI administration before eradication.
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
For upper abdominal symptoms of Helicobacter pylori (H. pylori) infected patients, proton pump inhibitor (PPI) are administrated before the eradication of H. pylori. If the upper abdominal symptoms were not improved after the eradication therapy, further administration of PPI are done .
20 | years-old | <= |
Not applicable |
Male and Female
Patients who are not administrated proton pump inhibitor (PPI) or administrated half dose of PPI.
Patients who are diagnosed atrophic gastritis with endoscopy.
Patients who are not diagnosed gastro-esophageal reflux disease (GERD) over the grade A of Los Angeles Classification, gastric ulcer, gastric cancer.
Patients who are not administrated non steroidal anti-inflammatory drugs (NSAIDs), major or minor tranquilizer, acotiamide every day.
Patients with history of gastrectomy.
Patients with severe renal or liver dysfunciton.
Patients with cancer.
Patients who have a history of failure of the first eradication of Helicobacter pylori.
230
1st name | |
Middle name | |
Last name | Hiroki Taguchi |
Kagoshima University Graduate School of Medical and Dental Sciences
Digestive and Life-style related Disease
8-35-1 Sakuragaoka, Kagoshima, Japan
099-275-5326
tag@m2.kufm.kagoshima-u.ac.jp
1st name | |
Middle name | |
Last name | Hiroki Taguchi |
Kagoshima University Graduate School of Medical and Dental Sciences
Digestive and Life-style related Disease
8-35-1 Sakuragaoka, Kagoshima, Japan
099-275-5326
tag@m2.kufm.kagoshima-u.ac.jp
Kagoshima University Graduate School of Medical and Dental Sciences, Digestive and Life-style related Disease
Kagoshima University Graduate School of Medical and Dental Sciences, Digestive and Life-style related Disease
NO
2014 | Year | 02 | Month | 03 | Day |
Unpublished
Completed
2013 | Year | 09 | Month | 01 | Day |
2013 | Year | 10 | Month | 01 | Day |
2014 | Year | 02 | Month | 03 | Day |
2016 | Year | 03 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015165
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |